Integra Lifesciences (IART) Stock Price, Quote & News

Company Profile

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cra...

Industry: Medical Devices

Sector: Healthcare

Phone: 609-275-0500

Fax: 609-750-4277

Website: www.integralife.com

Address:

1100 Campus Road, Princeton, United States

dred48 Mar. 9 at 6:16 PM

$IART getting near 2009 lows…how is the board still intact?

1 · Reply

scoobydoo16 Mar. 5 at 3:28 PM

$IART Proof that DEI doesn’t work. Should’ve bought Puts here. Oh, well. Maybe Berkshire can save the day and buy this. I’ll take $15.

1 · Reply

BillionerOfKing Mar. 4 at 4:47 PM

$IART Current Stock Price: $10.63 Contracts to trade: $10.0 IART Mar 20 2026 Call Entry: $0.90 Exit: $1.77 ROI: 96% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

scoobydoo16 Mar. 2 at 3:43 PM

$IART They need to fire Caruso, DiPetro, Smith, and Young. These people are responsible for all the issues that are sinking this ship. And put this ceo on a very short leash. What do they all have in common? That strategy does not work. Choose the best candidates. Period!!!

0 · Reply

ZacksResearch Mar. 2 at 2:16 PM

$IART beats on both EPS and revenue — and the stock is ticking higher 👀 Q4 topped estimates even with margin pressure and a sales dip. Now 2026 guidance is pointing to modest growth, giving the market something constructive to chew on. Is this the start of a steady rebound or just a relief bounce? Get the full breakdown 👉 https://www.zacks.com/stock/news/2877228/integra-q4-earnings-revenues-beat-estimates-margins-down-stock-up?cid=sm-stocktwits-2-2877228-teaser-35708&ADID=SYND_STOCKTWITS_TWEET_2_2877228_TEASER_35708

0 · Reply

ZacksResearch Mar. 2 at 1:16 PM

$IART beats Q4 estimates, but what's the real story? 🤔 While EPS topped the Zacks Consensus by 4.7%, both earnings and revenues fell year-over-year. Gross margin took a hit, contracting by 549 bps due to higher costs. See what this means for investors 👉 https://www.zacks.com/stock/news/2877228/integra-q4-earnings-revenues-beat-estimates-margins-down-stock-up?cid=sm-stocktwits-2-2877228-body-35704&ADID=SYND_STOCKTWITS_TWEET_2_2877228_BODY_35704

0 · Reply

MSUalum Feb. 26 at 5:36 PM

$IART expenditures higher than cash flow. Only 263M in cash and 1.6B in debt, combined with product issues. That is a STEEP hill to climb. Not sure they will make it out alive.

1 · Reply

StocktwitsEarnings Feb. 26 at 11:21 AM

$IART Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.02 down -108.00% YoY • Reported revenue of $434.93M down -1.74% YoY • For full-year 2026, Integra LifeSciences expects revenues between $1.66B and $1.7B, representing 1.6% to 4.1% reported growth. Adjusted EPS is projected between $2.30 and $2.40, reflecting tariffs offset by margin initiatives.

0 · Reply

SuperGreenToday Feb. 17 at 10:52 AM

$IART Share Price: $11.31 Contract Selected: Sep 18, 2026 $7.5 Calls Buy Zone: $3.90 – $4.82 Target Zone: $6.96 – $8.51 Potential Upside: 69% ROI Time to Expiration: 212 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

OfficialStocktwitsUser Feb. 12 at 6:25 PM

$IART RSI: 34.28, MACD: -0.4313 Vol: 0.59, MA20: 11.41, MA50: 12.37 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Integra LifeSciences Holdings Corporation (IART) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 6:00 AM EST - 23 days ago

Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance

Feb 17, 2026, 8:30 AM EST - 4 weeks ago

Integra LifeSciences Announces Key Executive Leadership Appointments

Feb 9, 2026, 6:35 AM EST - 5 weeks ago

Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026

Jan 14, 2026, 4:55 PM EST - 2 months ago

Integra LifeSciences Holdings Corporation (IART) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 5, 2026, 4:31 PM EST - 2 months ago

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 3, 2025, 12:43 PM EST - 3 months ago

Integra LifeSciences Holdings Corporation (IART) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 1, 2025, 4:30 PM EST - 3 months ago

Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference

Nov 25, 2025, 8:30 AM EST - 4 months ago

Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access

Nov 11, 2025, 4:15 PM EST - 4 months ago

Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries

Oct 30, 2025, 11:46 AM EDT - 5 months ago

Integra LifeSciences Holdings Corporation (IART) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 6:00 AM EDT - 5 months ago

Integra LifeSciences Reports Third Quarter 2025 Financial Results

Oct 15, 2025, 8:30 AM EDT - 5 months ago

Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025

Oct 8, 2025, 8:30 AM EDT - 5 months ago

Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting

Sep 22, 2025, 8:30 AM EDT - 6 months ago

Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer

Sep 10, 2025, 3:05 PM EDT - 6 months ago

Integra LifeSciences Still Recovering From Self-Inflicted Wounds

Sep 10, 2025, 11:59 AM EDT - 6 months ago

Integra LifeSciences Holdings Corporation (IART) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 29, 2025, 4:30 PM EDT - 7 months ago

Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences

Aug 1, 2025, 1:56 PM EDT - 8 months ago

Integra LifeSciences Holdings Corporation (IART) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 6:00 AM EDT - 8 months ago

Integra LifeSciences Reports Second Quarter 2025 Financial Results

Jul 14, 2025, 4:35 PM EDT - 8 months ago

Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025

Jul 2, 2025, 4:09 PM EDT - 9 months ago

Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA® Pediatric Registry

Jun 9, 2025, 8:30 AM EDT - 10 months ago

INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Integra LifeSciences Holdings Corp. and Encourages Long-Term Investors to Contact the Firm – IART

May 30, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Integra LifeSciences Holdings Corporation (IART) And Encourages Shareholders to Reach Out

May 29, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integra LifeSciences Holdings Corporation (IART) and Encourages Shareholders to Learn More About the Investigation

May 28, 2025, 10:00 AM EDT - 10 months ago

Integra LifeSciences Holdings Corporation (IART) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

May 27, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Shareholders to Inquire about Securities Investigation

May 26, 2025, 10:00 AM EDT - 10 months ago

Integra LifeSciences Holdings Corporation (IART) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 25, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Integra LifeSciences Holdings Corporation (IART) And Encourages Investors to Connect

May 23, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Stockholders to Inquire about Securities Investigation

May 22, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integra LifeSciences Holdings Corporation (IART) and Encourages Investors to Learn More About the Investigation

May 21, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Integra LifeSciences Holdings Corporation (IART) And Encourages Stockholders to Connect

May 20, 2025, 10:00 AM EDT - 10 months ago

Integra LifeSciences Holdings Corporation (IART) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 20, 2025, 5:31 AM EDT - 10 months ago

IART Investors Have Opportunity to Join Integra LifeSciences Holdings Corporation Fraud Investigation with the Schall Law Firm

May 19, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integra LifeSciences Holdings Corporation (IART) and Encourages Stockholders to Learn More About the Investigation

May 18, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Investors to Inquire about Securities Investigation

May 16, 2025, 2:00 PM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Integra LifeSciences Holdings Corporation (IART) And Encourages Investors to Reach Out

May 5, 2025, 1:54 PM EDT - 11 months ago

Integra LifeSciences Holdings Corporation (IART) Q1 2025 Earnings Call Transcript

May 5, 2025, 6:30 AM EDT - 11 months ago

Integra LifeSciences Reports First Quarter 2025 Financial Results

Apr 18, 2025, 4:30 PM EDT - 1 year ago

Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025

Mar 22, 2025, 12:10 PM EDT - 1 year ago

Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf

Mar 13, 2025, 5:00 PM EDT - 1 year ago

Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Mar 6, 2025, 7:23 AM EST - 1 year ago

Integra LifeSciences: Light At The End Of The Tunnel, Or Another Oncoming Train? (Rating Upgrade)

Feb 25, 2025, 10:50 AM EST - 1 year ago

Integra LifeSciences Holdings Corporation (IART) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 6:00 AM EST - 1 year ago

Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance

Feb 11, 2025, 4:30 AM EST - 1 year ago

Jan De Witte joins GHO Capital as Operating Partner

RMD

Feb 4, 2025, 10:34 AM EST - 1 year ago

Notice To Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf

dred48 Mar. 9 at 6:16 PM

$IART getting near 2009 lows…how is the board still intact?

1 · Reply

scoobydoo16 Mar. 5 at 3:28 PM

$IART Proof that DEI doesn’t work. Should’ve bought Puts here. Oh, well. Maybe Berkshire can save the day and buy this. I’ll take $15.

1 · Reply

BillionerOfKing Mar. 4 at 4:47 PM

0 · Reply

scoobydoo16 Mar. 2 at 3:43 PM

0 · Reply

ZacksResearch Mar. 2 at 2:16 PM

0 · Reply

ZacksResearch Mar. 2 at 1:16 PM

0 · Reply

MSUalum Feb. 26 at 5:36 PM

$IART expenditures higher than cash flow. Only 263M in cash and 1.6B in debt, combined with product issues. That is a STEEP hill to climb. Not sure they will make it out alive.

1 · Reply

StocktwitsEarnings Feb. 26 at 11:21 AM

0 · Reply

SuperGreenToday Feb. 17 at 10:52 AM

0 · Reply

OfficialStocktwitsUser Feb. 12 at 6:25 PM

0 · Reply

SorosSonosSatoshi Feb. 12 at 6:16 PM

$IART if this fallen so sharp..it should go to sinkhole at 6.666-8.888

0 · Reply

SorosSonosSatoshi Feb. 10 at 2:11 PM

$IART all 3 eyes 10.333 Slah With flash crash after that? To 9.333?

0 · Reply

scoobydoo16 Feb. 9 at 3:12 PM

$IART Disastrous management here. About time the BOD recommends some removals.

0 · Reply

OfficialStocktwitsUser Feb. 5 at 5:35 PM

$IART RSI: 24.20, MACD: -0.4949 Vol: 0.92, MA20: 11.93, MA50: 12.57 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

VolatilityVoyage Feb. 4 at 3:23 PM

$IART is a medical device company focused on orthopedic surgery; it operates in a competitive market with pricing pressure and the need for continuous innovation.

0 · Reply

SorosSonosSatoshi Feb. 3 at 10:49 AM

$IART all 3 eyes 9.3333 ,/9.666before that

0 · Reply

SorosSonosSatoshi Feb. 3 at 10:49 AM

$IART 60 to 10 buxxs. Seems Chinese robotic and AI in medical technology are. Going to rollout in Chinese surgery hospitalz. Death coffin ahead for iart 8.76543210 flash crash to 6.66 Be ready

0 · Reply

scoobydoo16 Jan. 20 at 3:32 PM

$IART DogShit stock.

0 · Reply

OfficialStocktwitsUser Jan. 14 at 3:10 AM

$IART RSI: 47.29, MACD: 0.0165 Vol: 0.45, MA20: 12.86, MA50: 12.60 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

smartkarma Jan. 6 at 6:45 PM

$IART | Primer: Integra Lifesciences Holdings (IART US) - Jan 2026 "Integra Lifesciences is currently navigating significant operational challenges, including a major product recall from its Boston facility,..." - αSK (Smartkarma) Read more: https://www.smartkarma.com/insights/primer-integra-lifesciences-holdings-iart-us-jan-2026

2 · Reply

Yukon_Cornelius22 Jan. 2 at 11:18 PM

$IART how’s the Acclarent division performing?

0 · Reply

AlgoExecution Dec. 25 at 3:48 PM

$IART Macro forces may influence direction, yet internal execution remains the decisive factor. Cost discipline must coexist with targeted investment. Any disconnect between guidance and outcomes will magnify skepticism. Future re‑rating depends on turning narrative into measurable outcomes.

1 · Reply

Market Cap	696.76M
Revenue (ttm)	1.64B
Net Income (ttm)	-516.47M
EPS (ttm)	N/A
PE Ratio	3.99
Forward PE	3.81
Profit Margin	-31.58%
Debt to Equity Ratio	1.74

Volume	1,684,600
Avg Vol	792,064
Day's Range	N/A - N/A
Shares Out	77.94M
Stochastic %K	22%
Beta	1.02
Analysts	Hold
Price Target	$16.00